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ABSTRACT 
 
ANALYSIS OF THE RELATIONSHIP BETWEEN THE INCIDENCE OF 
NAUSEA AND VOMITING IN THE USE OF CYCLOPHOSPHAMIDE, 
DOXORUBICIN AND VINCRISTINE CHEMOTHERAPY REGIMENS WITH 
THE QUALITY OF LIFE OF RETINOBLASTOMA PATIENS IN DR. SOETOMO 
HOSPITAL 
 
Ayu Diah Pratiwi, S.Farm., Apt. 
 
Background: Retinoblastoma is an intraocular malignant tumor that is most common in 
children. The incidence is 1 in 15,000 life births. The Children's Oncology Group (COG) 
recommends chemotherapy drugs that are used in intraocular retinoblastoma patients, 
vincristine, etoposide and carboplatin. While chemotherapy drugs used in extraocular 
retinoblastoma patients are vincristine, cisplatin, cyclophosphamide, and etoposide. 
Chemotherapy induced nausea and vomiting (CNIV) is one of the side effects of 
chemotherapy can make patients not follow chemotherapy properly. A systemic review 
study states that CINV has a major influence on the quality of life of patients. 
 
Objectives: The purpose of this study was to analysis the relationship between the 
incidence of nausea and vomiting in the use of cyclophosphamide, doxorubicin and 
vincristine chemotherapy regimens with the quality of life of retinoblastoma patients in Dr. 
Soetomo Hospital. 
 
Methods: Samples were collected from an observational analytic study with a prospective 
approach in August-October 2018. The method used was a survey method using the 
PedsQL 3.0 Cancer Module questionnaire, to describe the quality of life of retinoblastoma 
patients and Morrow Assessment of Nausea and Emesis Follow Up questionnaire, to 
measure the incidence of side effects of nausea and vomiting experienced by patients while 
undergoing chemotherapy, which then in statistical analysis to determine the correlation. 
 
Result: We enrolled 19 patiens. The results of this study were the Morrow Assessment of 
Nausea and Emesis Follow Up questionnaire instrument, which was higher than the 
incidence of acute and delayed nausea compared to the score of acute and delayed 
vomiting events with an average value of 1 ± 0.816. The highest quality of life dimension 
is found in the communication dimension with mean value 91.23 ± 21.779 while the lowest 
quality of life dimension score is in the procedural anxiety dimension with an average 
value of 48.68 ± 28.769. The results of Pearson correlation test showed that there was a 
negative relationship between the incidence of nausea and vomiting with the quality of life 
of retinoblastoma patients after being given cyclophosphamide, doxorubicin and 
vincristine chemotherapy regimens (p=0.040). 
 
Conclusions: Conclusion of this study is that the incidence of nausea and vomiting was 
associated with the poor quality of life of retinoblastoma patients after receiving 
cyclophosphamide, doxorubicin and vincristine chemotherapy regimens. 
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